19 October-1 December 2020
The 51st Union World Conference On Lung Health
REGISTER NOW

Sessions

All Sessions
keyboard_arrow_down
keyboard_arrow_down Show filters keyboard_arrow_up Hide filters
  • All Tracks
  • Community Connect
  • Channel 1
  • Channel 2
  • Channel 3
  • Channel 4
  • Channel 5
  • Channel 6
  • Channel 7
  • E-posters
  • Workshops
E-posters
EP33-Barriers in the TB care cascade: it's time for local solutions
event_note
Loading...
query_builder 10:00 - 11:00 | Event time (GMT+2)
query_builder - | Your time (GMT)
place Online Session/Virtual
card_travel E-poster session
mic English
EP33-Barriers in the TB care cascade: it's time for local solutions
*Please scroll down for more information*
All E-posters are accessible via the "E-posters" section of the conference platform until 30 November.

EP33-414-24-Barriers to care-seeking for TB in the Philippines: a qualitative study through the lens of behavioural scienceThrough the lens of behavioural science, qualitative research was conducted on care-seeking in communities with high prevalence of tuberculosis (TB) in the Philippines. Through interviews with people affected by TB, community members and health providers, the study investigated behavioural barriers to care-seeking faced by individuals experiencing symptoms suggestive of TB.
Emily Zimmerman

EP33-415-24-Does exposure to TB meetings, either small or large groups, improve the knowledge and health-seeking behaviour for early TB diagnosis? Experience from Bengaluru and HyderabadCommunity health workers conducted small, and large, group communication activities under Tuberculosis Health Action Learning Initiative (THALI), funded by the United States Agency for International Development, in two metro cities. Evaluation of the effect of these activities to improve the knowledge and health-seeking behaviours for tuberculosis.   
RAJARAM Potty

EP33-416-24-Community engagement activities reduce patient delays in TB diagnosis and treatment initiation in Bengaluru and Hyderabad cities, South IndiaWe conducted community engagement activities through trained community health workers in two metro cities in Southern India. The study highlighted the effect of these activities in improving the early diagnosis and treatment among tuberculosis patients accessing public health services.  
RAJARAM Potty

EP33-417-24-Provision of peer support by TB survivors to people with TB through the TB programme in India: successes, challenges and the way forwardIn-depth interviews were done to understand successes and challenges in provision of peer support by trained tuberculosis (TB) champions through the United States Agency for International Development's Call to Action project. Though the programme expressed need for more TB champions, there were varied levels of support to implementation. Orientation of programme staff would be required for institutionalisation of peer support.
Raghini Ranganathan

EP33-418-24-Addressing stigma in people living with drug-resistant TB in India: photovoice studyThis intervention explores the provision of Photovoice to understand multidrug-resistant TB-related stigma. Embedded within participatory action research, nine female patients at an Médecins Sans Frontières project in Mumbai, used Photovoice to understand their lived experiences of stigma and gauge the efficacy of it as a tool for alleviating stigmatic pain.
Tahiya Mahbub

EP33-419-24-Perceptions about TB and perceived TB-related stigma and associated factors among the mining community in EswatiniPerceptions about tuberculosis (TB) and factors associated with perceived TB-related stigma among the mining community in Eswatini, were assessed using a cross-sectional, descriptive, quantitative study design. The mining community perceives TB as very serious and expressed stigmatising thoughts, associated with age, period of stay in an area and certain geographical areas.
Charles Maibvise

EP33-420-24-Cost related to diagnosis and care endured by multidrug-resistant TB patients in a reference hospital in Cameroon: a transversal exploration.A preliminary part of a more complete study evaluates the costs that multidrug-resistant tuberculosis patients and their families, in a low-middle income country in Central Africa, endure when diagnosed and treated with a standardised, short course treatment regimen. More than 75% of the patients had catastrophic costs.  
Rikiatou Fandie

EP33-421-24-Coverage of health insurance schemes among Myanmar migrants with TB in a border area of Thailand and its associated factors: an interim analysisMigrants are vulnerable and important for tuberculosis (TB) control. Less than half of migrants with TB had health insurance (the focus was on documented migrants who are secured in working and living life). Strengthening health insurance among migrants is important to improve access to health services.
Myo Minn Oo

EP33-422-24-Social support for TB patients living in extreme poverty: experience from BangladeshSocial support overcomes the economic, geographical, sociocultural and health system barriers for tuberculosis (TB) patients, especially those who are living below the poverty line. Financial support for ultra-poor patients saves them from the catastrophic healthcare cost, which also ensures treatment adherence and a better outcome.
Sardar Munim Ibna Mohsin

EP33-423-24-Gender-wise differentials in coverage of social protection schemeGender differentials exist in the coverage of nutritional support incentives in the community. Understanding the social and cultural factors responsible for the differences would be crucial in ensuring gender-responsive services to all tuberculosis patients.
Deepak Balasubramanian

EP33-424-24-A nationwide survey of cross-border referral assistance (or lack thereof) for TB patients in JapanAdequate and effective referral for tuberculosis (TB) patients crossing national borders is critical in ensuring continuity of care, yet remains overlooked. We conducted a cross-sectional, nationwide survey to explore the situation of foreign-born TB patients, who are leaving Japan while still on treatment, and highlighted some issues.
Lisa Kawatsu

EP33-425-24-Barriers to TB preventive therapy initiation in people living with HIV in Cambodia: patients and clinicians perspectiveWe assessed barriers to tuberculosis preventive therapy (TPT) from people living with HIV and healthcare workers, in Cambodia, through focus group discussions. Side effects, adherence challenges and treatment duration with six months isoniazid, were the main barriers. Training, counselling and better tolerated, shorter regimens may improve TPT coverage.
Marion MORA

Loading...
E-posters
EPTBS-TBScience 2020 - E-posters - Displayed All Conference Days
event_note
Loading...
query_builder 10:00 - 11:00 | Event time (GMT+2)
query_builder - | Your time (GMT)
place Online Session/Virtual
card_travel E-poster session
mic English
EPTBS-TBScience 2020 - E-posters - Displayed All Conference Days
*Please scroll down for more information*
All TBScience 2020 E-posters will be displayed from 10 am Central European Summer Time (CEST), on Wednesday, 21 October for the duration of the conference and beyond

EP-TBS-01-Increased neutrophil count and decreased neutrophil CD15 expression correlate with TB disease severity and treatment response
Lerato Ndlovu

EP-TBS-02-Genome-wide identification of Mycobacterium tuberculosis genetic markers associated with the history of BCG vaccination
Kamela Charmaine S. Ng

EP-TBS-03-Characterization of regulatory B-cells for tuberculosis management
Irene Latorre

EP-TBS-04-Different antimycobacterial activity of alveolar macrophages in various lung legions of tuberculosis patients
Sergey Skornyakov

EP-TBS-05-Plasma mediators of phagocytosis in tuberculosis patients during anti-TB treatment and zinc supplementation
Victory Edem

EP-TBS-06-Discerning divergent tuberculosis endotypes: A meta-analysis of individual patient data
Andrew DiNardo

EP-TBS-07-Plasma Interferon (IFN)-g Inducible Protein 10 (IP-10) levels but not the QuantiFERON Gold plus assay correlate with disease severity and paradoxical reactions in extrapulmonary tuberculosis
Isabelle Suarez

EP-TBS-08-Host immune factors related to non-multidrug resistant tuberculosis with treatment history in Vietnam
Naoto Keicho

EP-TBS-09-Risk factors for the development of tuberculosis in children with chronic non-specific lung diseases.
Sofya Nakonechnaya

EP-TBS-10-Polyfunctional T-cells and IL-2 production decrease during pregnancy in women with latent TB infection
Jyoti Mathad

EP-TBS-11-Neutrophils Contribute to Tuberculosis-linked Inflammation and lung pathology
Caleb Nwongbouwoh Muefong

EP-TBS-12-Association of neutrophil-derived inflammatory mediator levels with lung pathology in active tuberculosis at diagnosis
Caleb Nwongbouwoh Muefong

EP-TBS-13-Characterising the BCG-induced antibody response for antigen discovery
Rachel Tanner

EP-TBS-14-ESAT-6 / CFP-10-stimulated metabolic activity of pleural fluid cells if cured tuberculosis or TB / HIV
Sergey Skornyakov

EP-TBS-15-Blood-Based Biomarkers of Tuberculosis in Children Integrating Metabolomic and Transcriptomic Data
Jeffrey A Tornheim

EP-TBS-16-Identification of TGF-β1 in pleural tuberculosis: the possible role in fibrosis
Silvio Renan Pinheiro Victor de Araújo

EP-TBS-17-Analysis of serum microRNAs as pulmonary tuberculosis biomarkers
JaeIn Jung

EP-TBS-18-Up-regulated programmed death protein 1 expression on CD4 T cells in patients with MDR-TB  associated with lung lesion and mycobacterial load
Qi Tan

EP-TBS-19-Malnutrition affects levels of vascular endothelial growth factor levels among children and adolescents with pulmonary tuberculosis?
Caio Pluvier Duarte Costa

EP-TBS-20-Towards identification of protein markers of Mycobacterium tuberculosis H37Rv extracellular vesicles (EV)
MEHALENE JAYARAM

EP-TBS-21-Increased frequency of CD39+ regulatory T cells in the pleural fluid of patients with Tuberculosisin comparison to other exudative causes
Ana Paula Santos

EP-TBS-22-Longitudinal analysis of M. tuberculosis-specific T cell responses demonstrates dynamic T cell responses to ESAT-6 and CFP-10 during pregnancy independently of mitogen responses.
Aparajita Saha

EP-TBS-23-Serum Cytokine Profile as Biomarker for Multi-drug Resistant Tuberculosis
Alahaman Nana Boakye

EP-TBS-24-Reanalysis and validation of Tuberculosis genes signature in blood and pleural fluid from patients with exudative pleural effusion
Raquel da Silva Corrêa

EP-TBS-25-TimBre, Cough based screening of Pulmonary Tuberculosis using Machine Learning that is Explainable and Interpretable
Rahul Pathri

EP-TBS-26-HbA1C as prognostic factor in PTB
Sarang Patil

EP-TBS-27-Better intradermal delivery for bacille Calmette-Guérin (BCG) vaccine by microneedles in healthy adults of S. Korea
Hyejon Lee

EP-TBS-28-MULTIPLEX BIOMARKER ASSAY FOR DETECTION OF MYCOBACTERIUM TUBERCULOSIS
Puneet Gupta

EP-TBS-29-Role of the chemokine receptor CXCR3 in the recruitment and retention of lung resident memory T cells following a pulmonary TB vaccine. 
Warwick Britton

EP-TBS-31-Benefit of Quantiferon-TB Gold plus in incidence of TB disease in Heath care workers of Central Chest Institute of Thailand
piamlarp sangsayunh

EP-TBS-32-The blood monocyte/lymphocyte, neutrophil/lymphocyte and platelet/lymphocyte ratios in children with pulmonary tuberculosis
Larissa Gorbach

EP-TBS-33-Pulmonary tuberculosis patients have an anaerobe-enriched microbiota associated with a pro-inflammatory peripheral host immune phenotype
Charissa Naidoo

EP-TBS-34-The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on rifampicin resistant and multidrug resistant tuberculosis in India and China
Chathika Weerasuriya

EP-TBS-36-Novel, culture-free, same-day TB diagnosis with ultrasensitive ELISA
Rikiya Takeuchi

EP-TBS-37-Tuberculosis screening in point-of-care settings: Proof-of-concept for a fast and easy sample-to-answer qPCR-based protocol
Alexandre Dias Tavares Costa

EP-TBS-38-Diagnostic accuracy of three urine lipoarabinomannan tuberculosis assays in HIV-negative outpatients
Tobias Broger

EP-TBS-39-To Study The Presence Of Live Mycobacterium Tuberculosis In Resected Lung Specimens Of Patients Undergoing Lung resection Surgery For Post-Tuberculosis Sequelae
Pallavi Purwar

EP-TBS-40-What can tuberculosis prevalence surveys tell us about the duration of asymptomatic bacteriologically-positive disease?
Chu-Chang Ku

EP-TBS-41-An RNA signature for tuberculosis risk in pregnant women: a prospective cohort study from India
Jyoti Mathad

EP-TBS-42-Analysis of mycobacterial trans-renal DNA for the diagnosis of Tuberculous Meningitis in adults.
Manisha Dass

EP-TBS-43-Developing a tool to identify and screen Latent Tuberculosis Infection (LTBI) with likelihood of progression to active Tuberculosis (ATB)
Prashant Singh

EP-TBS-44-QuantiFERON TB plus-negative results in clinically diagnosed paediatric tuberculosis: immune suppression or misdiagnosis?
Gloria Ivy Mensah

EP-TBS-45-Evaluation of a blood-based antigen test for tuberculosis in HIV-exposed children younger than 5 years
Tony Hu

EP-TBS-46-Adverse drug reactions in MDR TB Patients on ATT
Sarang Patil

EP-TBS-47-Species and Drug Susceptibility profile of Non-tuberculous Mycobacteria isolated from presumptive TB cases
PRIYA RAJENDRAN

EP-TBS-48-MAMA-PCR assay for the detection of point mutations associated with drug resistance in Mycobacterium tuberculosis clinical isolates
Raquel Muñiz-Salazar

EP-TBS-49-Genomic diversity in Mycobacterium tuberculosis from human lung resections reveals a high degree of multiclonal infections in a high-burden MDR-TB setting
Miguel Moreno-Molina

EP-TBS-50-Pathogen genome sequencing to guide treatment regimen designs for multidrug-resistant tuberculosis
Hans-Peter Grobbel

EP-TBS-51-An evolutionary functional genomics approach identifies novel candidate regions involved in isoniazid resistance in Mycobacterium tuberculosis
Victoria Furió

EP-TBS-52-Antibiotic Resistance Profile Determination Using Whole Genome Sequencing
Ryan Howard

EP-TBS-53-Rapid genomic drug resistance prediction from clinical Mycobacterium tuberculosis specimens using amplicon based deep sequencing based on Deeplex-MycTB
Stefan Niemann

EP-TBS-54-Multi-resistant tuberculosis and HIV infection in Kinshasa: 2011-2018. DRC “Epidemiological, clinical and therapeutic aspects”
Nicole ANSHAMBI

EP-TBS-55-Long Read DNA Sequencing of XDR/MDR Tuberculosis Samples to Investigate Factors Leading to Resistance and Virulence
Michael Harris

EP-TBS-56-Genome-wide detection of epistasis in antibiotic resistant M. tuberculosis
Anna Green

EP-TBS-57-Population structure, biogeography and transmissibility of Mycobacterium tuberculosis
Luca Freschi

EP-TBS-58-Safety and Efficacy of an MDR-TB All-oral Short-course Regimen in China: An Preliminary Analysis of the MDR-Chi clinical trial
Liang Fu

EP-TBS-59-Drug exposure and minimum inhibitory concentration predict pulmonary tuberculosis treatment response
Xubin Zheng

EP-TBS-60-A novel therapeutic vaccine against multi-drug resistant tuberculosis by T cell-immunity in phase 1 clinical trial.
Masaji Okada

EP-TBS-61-Improving the safety of TB therapy with novel diagnostic biomarkers of liver toxicity – a study in UK and Ugandan patients
Derek Sloan

EP-TBS-62-Tuberculosis meningitis mouse model
Tuhina Gupta

EP-TBS-63-Pharmacokinetics of the three-drug fixed-dose dispersible tablet in children
Aziza Pakhlavonova

EP-TBS-64-Does BCG Vaccination protect against infection with Mycobacterium tuberculosis in Vietnamese schoolchildren?
Puck Pelzer

EP-TBS-65-Time to positivity as a surrogate biomarker of time to culture conversion
Belén P. Solans

EP-TBS-66-Use of the contact management register to identify those with Active and Latent TB, Kenya, Jan-March 2020
RHODA POLA

EP-TBS-67-Predicting Efficacy Outcome of Nine Tuberculosis Drugs in Phase 2a First-in-patients Studies
Nan Zhang

EP-TBS-69-Predicting optimal treatment durations for tuberculosis patients: a risk stratification algorithm and clinical simulation tool
Marjorie Imperial

EP-TBS-70-Adverse Drug Reactions in MDR TB Patients on Category IV Regimen in Western Odisha
SUMAN KUMAR JAGATY

EP-TBS-71-The effect of antiretroviral therapy and preventive tuberculosis therapy with anti-TB drugs on the duration of TB remission in HIV-infected patients
Igor Medvinskiy

EP-TBS-72-A Urine Colorimetric Assay for Levofloxacin Concentrations and Optimized Regimen Development
Prakruti Rao

EP-TBS-73-Development and Application of an Integrated Biomarker - Clinical Endpoint Tool for Late Stage TB Regimen Development and Clinical Trial Design
Marjorie Imperial

EP-TBS-74-Leveraging Neural Networks and Imaging Experts in Loops for Automated Tuberculosis Screening Using Chest Radiographs in Population Screening Programs to ensure efficient workflows.
Amit Kharat

EP-TBS-75-A model for the integration of traditional medicine into conventional medicine for the treatment of Tuberculosis (TB) in Zimbabwe
Winnet Enerita Chipato

EP-TBS-76-Point-of-Care Saliva Assay for Levofloxacin Concentrations and Personalized Dosing in Patients with Multidrug-Resistant Tuberculosis in Tanzania
Sagal Mohamed

EP-TBS-77-PBPK Model Informed Prediction to Evaluate the Effect of Renal Impairment and OCT genotypes on the Ethambutol Disposition
Yumi Park

EP-TBS-78-Development of Population Pharmacokinetic Model of the First-line anti-TB drugs in Korean patients with TB for Therapeutic Drug Monitoring Guided Dose Adjustment
Yumi Park

EP-TBS-79-Model Informed Personalized Dosing Algorithm Development for TB Therapy in Center for Personalized Precision Medicine (cPMTb)
Yumi Park

EP-TBS-80-Classifying adherence trajectories: an innovative tool for regimen development
Stephanie Law

EP-TBS-81-Predicting pretomanid penetration into patient lesions of tuberculosis
Jacqueline Ernest

EP-TBS-82-Rifapentine pharmacokinetics and pharmacodynamics: murine and human models to identify optimal dosing for treatment of latent M. tuberculosis infection
Jacqueline Ernest

EP-TBS-83-SLCO1B1 and SLC10A1 polymorphism and plasma rifampin concentrations in patients with co-morbidity tuberculosis-diabetes mellitus in Baja California, Mexico
Ricardo Perea-Jacobo

EP-TBS-84-Individual-Level Data Meta-Analysis of Adverse Events from Clinical Trials of Drug Sensitive Tuberculosis Treatment Regimens
Leah Jarlsberg

EP-TBS-85-G-clamp-inspired ligands and their effects on G-quadruplexes from Mycobacterium tuberculosis
Egor Shitikov

EP-TBS-86-Prediction of early bacterial activity (EBA) of bedaquiline in tuberculosis
Federico Romano

Loading...
E-posters
EP34-TB: from bench to the bedside
event_note
Loading...
query_builder 10:00 - 11:00 | Event time (GMT+2)
query_builder - | Your time (GMT)
place Online Session/Virtual
card_travel E-poster session
mic English
EP34-TB: from bench to the bedside
*Please scroll down for more information*
All E-posters are accessible via the "E-posters" section of the conference platform until 30 November.

EP34-426-24-Sensitivity of diagnostic tests in people with abnormal chest radiographsTo increase the detection of tuberculosis (TB) cases in high burden communities, we piloted an active case finding intervention using mobile X-ray vans. We describe the diagnostic characteristics of the individuals diagnosed with TB with this intervention.
Daniela Vanesa Puma Abarca

EP34-427-24-Targeted intervention to strengthen treatment monitoring using follow-up sputum testing among ambulatory, pulmonary multidrug-resistant TB patients in Xi`an, western ChinaTargeted education, counselling and follow-up support to strengthen treatment monitoring, through increased uptake of required, regularly scheduled sputum testing among ambulatory, pulmonary multidrug-resistant TB patients, managed by Xi’an Chest Hospital, Xi`an City, western China
Hui Luo

EP34-428-24-Using Xpert among symptomatic people with negative sputum smear microscopy results in Maharasthra: a key to identifying missing TB patientsImproving access to Xpert services among smear-negative cases with abnormal chest X-ray leads to an increase in notification. One hundred and sixty-seven individuals with a negative smear result on microscopy, but with an abnormal chest X-ray, were not initiated on treatment. When tested on Xpert their result was positive, leading to an increase in notification of MTB cases.
Ashvini Vyas

EP34-429-24-Novel RNA markers of anti-TB treatment responseCurrent measurements of drug efficacy in tuberculosis (TB) clinical trials rely on the cultivation of the pathogen where the effect of sterilising agents on the persister population is unmeasurable. Our novel pre-16S/16S rRNA model represents an innovative measure of drug efficacy and potential to accelerate clinical trials of TB drugs.
Evelin Dombay

EP34-430-24-Low AUC/MIC target attainment of moxifloxacin during treatment of patients with multidrug-resistant TB in ChinaTherapeutic drug monitoring of key multidrug-resistant tuberculosis (MDR-TB) drugs aims to ensure sufficient drug exposure in order to improve treatment outcome. In this study including patients with MDR-TB in China, we explored the target attainment of drug exposure in relation to individual minimum inhibitory concentration for moxifloxacin, compared to previously suggested targets.
Lina Davies Forsman

EP34-431-24-Effective stock management of GeneXpert test cartridges in health facilities for uninterrupted TB laboratory diagnosis in three urban districts in UgandaThe World Health Organization recommends Xpert MTB/RIF assay as an initial tuberculosis (TB) diagnostic test. In Uganda there are 237 GeneXpert sites. However, testing is affected by stock-outs of cartridges. The United States Agency for International Development's Defeat TB project worked in facilities to reduce stock-outs through weekly review of stock cards, cartridge re-distributions and monthly physical counts.
Ronald Mangeni

EP34-432-24-The efficacy of anti-TB therapy and treatment outcome are modulated by the magnitude of bactericidal activity on the rest of respiratory microbiomeOur findings show that the efficacy of anti-tuberculosis therapy is modulated by the extent of its action on the rest of the respiratory microbiome.  Conversion to culture negative by week eight of treatment was associated with significant reduction of Streptococcus and overall microbiome diversity.
Wilber Sabiiti

EP34-433-24-Impact of the human resource support scheme and sample transportation system on GeneXpert services in selected states in Nigeria: the KNCV/Challenge TB experienceNigeria experienced huge demand for GeneXpert testing following adoption as the initial diagnostic test for tuberculosis (TB). Despite the installation of 398 machines, utilisation rates remained low. To improve utilisation of machines, KNCV and the Challenge TB project, through United States Agency for International Development funding, implemented the GeneXpert human resource support scheme and courier model of sample transportation.
Nkiru Nwokoye

EP34-434-24-Synthesis and evaluation of new compounds efficient against Mycobacterium TB isolates circulating in a high burden country, Russian FederationMycobacterium tuberculosis strains resistant to anti-tuberculosis (TB) drugs continue to circulate and present a global problem. Here, we performed synthesis of new compounds containing 2-aminobutanol moiety and tested their efficiency on M. tuberculosis clinical isolates from Russia, a high burden country for multi- and extensively drug-resistant TB.
Anna Vyazovaya

EP34-435-24-Improvement of elimination rate of Mycobacterium tuberculosis in sputum among patients receiving a bedaquiline and/or linezolid- containing regimens in TanzaniaWe present how molecular bacterial load assay (TB-MBLA) was used to test whether the killing of M. tuberculosis in adult patients, with either drug-resistant or susceptible tuberculosis, depends on the treatment regimens. 
Peter M. Mbelele

Loading...
E-posters
EP37-Joining efforts for TB elimination: the role of the private sector
event_note
Loading...
query_builder 10:00 - 11:00 | Event time (GMT+2)
query_builder - | Your time (GMT)
place Online Session/Virtual
card_travel E-poster session
mic English
EP37-Joining efforts for TB elimination: the role of the private sector
*Please scroll down for more information*
All E-posters are accessible via the "E-posters" section of the conference platform until 30 November.

EP37-455-24-Is it worth investing additional resources to catalyse access to TB care in the private sector? An experience from southern IndiaOur study aims to assess the impact of additional project investments on access to TB care services, like microbiological confirmation of diagnosis, universal DST and linkage to government portals by notification, thereby enabling access to incentives etc. Our learning from southern India can be generalised for Indian context and holds high significance in resource-constraint settings.
Vaibhav Ghule

EP37-456-24-The importance of using systematic screening in high TB burden countries to improve case detection rates: a case from private clinical facilities in NigeriaSystematic screening is key to tuberculosis (TB) case detection in high TB burden countries like Nigeria. The United States Agency for International Development SHOPS Plus programme engaged private clinical facilities in Lagos and Kano States to increase case detection though screening and testing. We compared screening, testing and case finding rates between supported hospitals and nursing homes.
Flora Nwagagbo

EP37-458-24-Factors affecting Nigerian private health facilities' TB case finding performance: reviewing programme dataThe United States Agency for International Development's SHOPS Plus Nigeria programme has engaged over 500 private health facilities in Lagos and Kano States to increase case detection. SHOPS Plus assessed the performance of its networked clinical facilities, using service delivery data, so it could better target oversight and diagnostic resources.
Abdu Adamu

EP37-459-24-Improving quality of care in private sector patients: state of Uttar Pradesh, IndiaCase finding in the private sector has been a challenge which was successfully overcome by the Joint Effort for Elimination of Tuberculosis (JEET) project. However, providing quality of care to these diagnosed tuberculosis (TB) patients in the private sector was another area which the JEET team took up as a challenge and managed to improve through state government collaboration.
Bharati Kalottee

EP37-460-24-The experience of engaging private pharmacies in TB case detection in EthiopiaWe present an innovative experience of engaging private pharmacies and drug vendors in tuberculosis (TB) case detection in Ethiopia. By engaging 110 private pharmacies and drug vendors, we contributed to the detection of 699 additional TB cases (21%) compared with a 1% decline in the control zone. The approach should be expanded.
Samson Ogayse

EP37-461-24-The Global Fund public-private mix TB grant: impact in three southern states in NigeriaThe private sector constitutes a majority of the Nigerian healthcare system. However, only 2.5% of these facilities are formally engaged for tuberculosis services, contributing 11% to total case notification in the country. We present the preliminary findings on the impact of private sector engagement in three states of southern Nigeria.
Chukwuka Alphonsus

EP37-462-24-How frequently are TB care providers changed in the private sector in rural Bihar, India?Provider switching can impact patient care and result in a high-cost of care in the private sector. Understanding its nature and reasons are crucial to addressing it in the tuberculosis programmes engaging the private sector.
Smriti Ridhi

EP37-463-24-Initiation of preventive treatment among household contacts of TB patients registered at a private healthcare facility in Karachi, PakistanInvestigation for tuberculosis (TB) infection in household contacts of individuals with known TB, can lead to early diagnosis and prompt treatment initiation as well as helping to reduce the transmission cycle. In 2019, post-exposure treatment (PET) was initiated for household contacts at a specialised TB diagnostic and treatment centre in the private sector Karachi, Pakistan.
Wafa Jamal

EP37-464-24-Emerging trends in private sector notifications in India: experiences from the Joint Effort for Elimination of Tuberculosis projectThe abstract documents the experiences of implementing the Joint Effort for Elimination of Tuberculosis project (JEET) in geographies covered by FIND India and analyses trends over the years. Comparisons have been drawn with districts where JEET is not being implemented.
Aakshi Kalra

EP37-465-24-Establishment of TB Diagnostic Hubs in Selected Private LaboratoriesEstablishing TB diagnostic hubs in urban private facilities that are surrounded by a rich network of spokes reduces access barriers and hence provide a fertile ground for ACF interventions. Hub and spoke model coupled with a web-based system and a rider, minimizes the leakages in the care cascade. 
Drusilla Nyaboke

Loading...
E-posters
EP36-Molecular testing for TB infection and drug resistance
event_note
Loading...
query_builder 10:00 - 11:00 | Event time (GMT+2)
query_builder - | Your time (GMT)
place Online Session/Virtual
card_travel E-poster session
mic English
EP36-Molecular testing for TB infection and drug resistance
*Please scroll down for more information*
All E-posters are accessible via the "E-posters" section of the conference platform until 30 November.

EP36-445-24-Effect of switching from Xpert® MTB/RIF to Xpert® MTB/RIF-Ultra on tests done and TB cases diagnosed in Uganda: a case of assay superiority?This switch was supposed to give us more tests with an increased sensitivity of 12%-17%. Our study did not find this. We hypothesis that, if the health systems approach had been taken during the switch, all the potential benefits of the new assay would have been realised.
Michael Kakinda

EP36-446-24-Factors associated with drug-resistant TB among prisoners in Sāo Paulo State, BrazilThis study investigated the determinants of drug-resistant tuberculosis (DR-TB) among prisoners in the state of São Paulo, Brazil. It involved a retrospective cohort of DR-TB cases among prisoners. Sputum smear and culture, chest X-ray, AIDS, alcoholism and background treatment history for TB, were determinants associated with resistance to anti-TB drugs among prisoners.
Ricardo Arcêncio

EP36-447-24-Did expansion of GeneXpert machines find missing TB patients? Experience from NigeriaFrom commencement of GeneXpert implementation in 2011 to 2019, 407 GeneXpert machines (less than 45% geographical coverage across 774 local government areas) were installed in Nigeria. Starting from 2017, the TB programme shifted emphasis to GeneXpert service optimisation (47% utilisation rate) and halted installation of more machines.

Sani Useni

EP36-448-24-Xpert MTB/RIF Ultra improved the diagnosis of tuberculous meningitis in HIV-negative patients: a prospective studyThe role of Xpert MTB/RIF Ultra (Xpert Ultra) in diagnosing tuberculous meningitis(TBM) is uncertain. Implementation of Xpert Ultra in different epidemiological and geographical settings with different patient populations, might gain different benefits. We evaluated the performance of Xpert Ultra for TBM diagnosis in HIV-negative patients in China.
Mailing Huang

EP36-449-24-Hypothetical yield of serial TB screening using Xpert MTB/RIF among people living with HIV in Kampala, UgandaRoutine intensified case finding (ICF) for tuberculosis is recommended for people with HIV in TB-endemic areas, but its yield is unclear. We compared the estimated yield of two strategies - 1. baseline ICF with culture and Xpert, plus three-month ICF with Xpert only, and 2. baseline and three-month ICF with Xpert only.
Lelia Chaisson

EP36-450-24-Prevalence of gene mutations profiles by GenoType MTBDRplus in isoniazid Mycobacterium tuberculosis-resistant strains, Tunisia 2015-2019Mutations in katG and inhA promotor are involved respectively in 93.2% and 21.4% of isoniazid resistant M. tuberculosis strains. 
The aim of this study is to determine the genetic profiles of isoniazid-resistant M. tuberculosis strains in Tunisia during 2015-2019, using the molecular assay, GenoType MTBDRplus V2.0
Imen Bouzouita

EP36-451-24-Evaluation of BD MAX multidrug-resistant TB assay for detection of Mycobacterium tuberculosis complex and mutations associated with rifampicin and isoniazid resistanceEmergence of multidrug resistance in Mycobacterium tuberculosis complex (MTBC) and the length of time to diagnosis, are challenges to global tuberculosis control. New technologies, such as BD MAX MDR-TB, offer faster time to diagnosis, allowing effective treatment without a delay. We assessed suitability of the assay for use in the clinical setting.
Seb Cotton

EP36-452-24-Culture positivity rates among rifampicin-resistant indeterminate patients tested using Xpert® MTB/RIF-Ultra in high TB-HIV care settings: Uganda case studyThe World Health Organization recommends additional testing using culture and drug susceptibility testing (DST) methods for all patients initially tested with the Xpert® MTB/RIF-Ultra technique, and whose rifampicin resistance pattern is indeterminate. We determined the culture positivity rates among 75 rifampicin-resistant indeterminate patients in high TB-HIV care settings.
Didas Tugumisirize

EP36-453-24-A novel standardised artificial sputum for external quality control of the whole TB diagnostic workflowCurrently there is no validated test matrix for externally monitoring the quality of sputum-based TB diagnostics (EQA) including smear-microscopy, culture and molecular testing. We have developed a novel mucin-based artificial sputum (MUCAS) suitable for EQA panels assessing the performance of Ziehl-Neelsen microscopy, mycobacterial culture and molecular diagnostics.
Markus Beutler

EP36-454-24-The sensitivity and specificity of Xpert MTB/RIF Ultra in an active TB case finding setting and understanding the 'trace call' resultThe GeneXpert Ultra is a recent development in tackling the limitations of the MTB/Rif assay for diagnosis of paucibacillary tuberculosis. Interpretation of the 'trace call' result is a challenge, especially when used in an active case finding setting. What is new about the Xpert Ultra and the 'trace call' result?
Lophina Chilukutu

Loading...
E-posters
EP32-Quality improvement of the TB cascade of care
event_note
Loading...
query_builder 10:00 - 11:00 | Event time (GMT+2)
query_builder - | Your time (GMT)
place Online Session/Virtual
card_travel E-poster session
mic English
EP32-Quality improvement of the TB cascade of care
*Please scroll down for more information*
All E-posters are accessible via the "E-posters" section of the conference platform until 30 November.

EP32-404-24-Evaluation of TB active case finding cascade: results from a TB surge intervention in Akwa Ibom State, NigeriaActively finding tuberculosis through screening of all hospital attendees and instituting multiple testing options, will widen the chances of finding the missing cases within the health facility. Due to poor health-seeking behaviour and lack of awareness, most persons will not seek medical attention because of a cough.
Ifiok Ekanim

EP32-405-24-Pay for performance to optimise the TB care cascade and improve quality of services at high volume health facilities in KenyaThrough Global Fund support, Amref Health Africa - in collaboration with the national tuberculosis (TB) programme in Kenya - is implementing a pay for performance initiative in 197 high volume health facilities in 13 high TB burden counties. Facilities earn money for additional TB cases notified and quality of TB services offered. 
Anne Gorreti Munene

EP32-406-24-Cascade analysis for active TB case finding intervention in Nigeria: a tool for quality improvement and programme monitoringKNCV Nigeria constructed a cascade to assess clients’ retention across tuberculosis (TB) screening stages. Based on epidemiological data, we set targets for each stage and designed a template for weekly data monitoring and cascade analysis to measure gaps. We did root cause analysis and designed specific interventions to address identified gaps.
Ogoamaka Chukwuogo

EP32-407-24-Impact of TB cascade loss in a facility-based, intensified TB case finding intervention in Nasarawa State, NigeriaThe review of the impact of loss of patients in a cascade during facility-based screening activities has the potential to undermine efforts to find missing tuberculosis (TB) cases in Nigeria. This can lead to programmatic under-reporting and an increase in the spread of TB in communities
Daniel Egbule

EP32-408-24-Implementation and scale-up of TB Clinic-Laboratory Continuous Quality Improvement (TB CLICQI) in Nigeria: Lessons learntTuberculosis clinic/laboratory continuous quality improvement (TB CLICQI) was a proof of concept in Nigeria. It was piloted and implemented in Benue State and the outcome fueled the scale-up. This present study documents the impact and lessons learned during the scale-up at selected states and health facilities.
Laura Madukaji

EP32-409-24-Finding additional TB cases through symptom screening for diagnosis in high burden setting: cough of two weeks is not enoughSystematic screening for tuberculosis (TB) in health facility settings and among priority groups remains an important active case finding strategy in high TB burden countries. National TB programmes will benefit through more attention to accurate diagnosis and earlier start of treatment.
Chidubem Ogbudebe

EP32-410-24-Prevalence of Mycobacterium tuberculosis in sputum among adult clinic attendees compared with the surrounding community in rural South Africa: implications for finding the missing millionsThis analysis compares the findings of a tuberculosis prevalence survey, conducted within primary healthcare clinics, to a community-based survey during the same period. Characteristics of enrolled participants, as well as those with a sputum culture positive for Mycobacterium tuberculosis, are compared.
Indira Govender

EP32-411-24-A country tailored package approach to TB case finding: Challenge TB project experience across 23 countriesHierarchy of tuberculosis (TB) case finding interventions, based on yield, from strengthening healthcare facility TB screening (highest) to TB index case contact investigation (least) and the use of a package approach, driven by patient health-seeking behaviour, and pathway to accessing TB diagnosis and care.
Mustapha Gidado

EP32-412-24-Enhancing the performance of newly established TB services sites through the incorporation of structured demand creation activities in Nigeria: findings from a non-randomised intervention studyTuberculosis (TB) prevention is largely ensured by early case identification and treatment in Nigeria among the non-HIV infected populations. Enhancing the performance of newly established TB service sites, through the incorporation of structured demand creation activities, improves case detection and, thus, prevention of TB.
Aminu Babayi

EP32-413-24-Towards achieving UN General Assembly political declaration on HIV and AIDS: commitment on TB case finding among PLHIV, in IndiaThe study assesses the improvement in coverage of intensified case finding among persons living with HIV, in India, as a result of a collaborative, multipronged approach involving capacity building and periodic supervision of the activity.
Deepak Balasubramanian

Loading...
E-posters
EP29-The European TB experience
event_note
Loading...
query_builder 10:00 - 11:00 | Event time (GMT+2)
query_builder - | Your time (GMT)
place Online Session/Virtual
card_travel E-poster session
mic English
EP29-The European TB experience
*Please scroll down for more information*
All E-posters are accessible via the "E-posters" section of the conference platform until 30 November.

EP29-376-24-Exploring the differences between groups of tTB cases with unknown treatment outcomes in GermanyReporting tuberculosis (TB) treatment outcomes is important to improve its control efforts. We investigated the characteristics of TB patients with unknown treatment outcomes in Germany. We observed important differences between patients, whose treatment outcomes were reported as missing and as unknown, due to transfer of the patient to different jurisdiction area.
Teresa Domaszewska

EP29-377-24-Can future TB cases be predicted in the Netherlands? What you see is what you get!The extent of tuberculosis (TB) data collection in surveillance systems differs by country. In the Netherlands, data is collected on country of birth and duration of stay/residence of foreign-born patients. This study presents trends for different sub-groups i.e. patients born in the Netherlands and foreign-born patients, by time, in the Netherlands.
Gerard De Vries

EP29-378-24-TB healthcare-seeking among contacts of active TB patients: evaluation of symptom screening in a nationwide contact investigation in the country of GeorgiaWe conducted a cohort study among contacts of patients with tuberculosis (TB) from Georgia. Contacts received TB symptom screening and were referred to care. Less than half of contacts with symptoms received diagnostic testing for active TB and TB incidence was almost seven times higher among symptomatic contacts, compared to asymptomatic contacts.
Ana Giguashvili

EP29-379-24-Molecular characterisation of Mycobacterium tuberculosis isolates in the Russian region with unexpectedly low TB incidenceThe Vologda region is located in the north of the European part of Russia and is characterised by an unexpectedly low tuberculosis (TB) incidence rate of 15.8 /100,000 (Russian average - 44.4). This situation is intriguing and we analysed Mycobacterium tuberculosis population structure to understand the likely underlying, pathogen related factors.
Anna Vyazovaya

EP29-380-24-Treatment of rifampin-resistant TB with an all-oral regimen containing new drugs in Zhytomyr UkraineUkraine is a country with high burden rifampin-resistant and multidrug-resistant forms of tuberculosis (RR/MDR-TB) and poor treatment success rates. We assess the effectiveness, safety and tolerability of an all-oral, nine-12 month regimen, containing bedaquiline with levofloxacin or delamanid, for the treatment of RR/MDR-TB in Zhytomyr, Ukraine.
Chung-Yu Chen

EP29-381-24-Implementation and acceptance of video consultation in the treatment and care of drug-sensitiveTB and latent TB infection in The NetherlandsNurses who are specialised in tuberculosis (TB) management, counsel patients with latent TB infection during their treatment. eHealth, in the form of video consultation, has the potential to support counselling. This study focused on the acceptance of video consultation, both by patients and nurses, and aimed to provide guidance for nurses considering video consultation.
Simone Boerema

EP29-382-24-A European TB strategy toolkit: supporting the development and strengthening of national TB programmes in the European Union and European Economic Area Member StatesA European TB strategy toolkit, commissioned by the European Commission and supported by the European Centre for Disease Prevention and Control, and World Health Organization Europe, has been developed. It supports prioritisation of areas for action and equips Member States with underpinning European Union/European Economic Area-focused evidence in developing national strategic TB plans to move countries, and Europe, toward TB elimination. 
Fatima Wurie

EP29-383-24-The use of totally implantable central venous access ports system for the treatment of multidrug-resistant TB: Belarus prospective cohort studyTotally implantable, central venous access port system (CVP) helps to provide multidrug-resistant tuberculosis treatment with carbapenem- containing regimens. Following a pilot project (supported by Médecins Sans Frontières) CVP use was programmatically expanded with Global Fund support. In a countrywide cohort, CVP demonstrates a good safety profile and a high level of patient acceptability.
Aliaksandr Skrahin

Loading...
E-posters
EP30-Where are the undiagnosed TB cases?
event_note
Loading...
query_builder 10:00 - 11:00 | Event time (GMT+2)
query_builder - | Your time (GMT)
place Online Session/Virtual
card_travel E-poster session
mic English
EP30-Where are the undiagnosed TB cases?
*Please scroll down for more information*
All E-posters are accessible via the "E-posters" section of the conference platform until 30 November.

EP30-384-24-Active TB case finding targeted at high burden health facilities in Nigeria: results from a pilot interventionSystematic screening for tuberculosis (TB) in health facility settings and among priority groups remains an important active case finding strategy in high TB burden countries. National TB programmes will benefit through more attention to accurate diagnosis and earlier start of treatment.
Chidubem Ogbudebe

EP30-385-24-Improving TB case finding in hospital outpatient departments: lessons from a health system strengthening approachSystematic screening for tuberculosis (TB) in health facility settings and among priority groups remains an important active case finding strategy in high TB burden countries. National TB programmes will benefit through more attention to accurate diagnosis and earlier start of treatment.
Chidubem Ogbudebe

EP30-386-24-Achieving End TB Strategy: screening for TB in pregnant and non-pregnant women in reproductive age group. Findings from an observational study in Pune, IndiaReproductive age women face a higher risk of tuberculosis (TB) transmission, morbidity and mortality. But women’s access to healthcare is restricted. This study discusses prevalence of active/suspected and latent TB in pregnant and non-pregnant women screened for TB in a hospital in Pune, India. It also discusses he challenges faced for screening.
Mallika Alexander

EP30-387-24-Active case finding for TB among factory workers in Punjab, IndiaFactories are one of the key areas for tuberculosis (TB) prevention and control activities. However, an apprehension of losing employment continues to deter factory workers from participating in TB screening. In close co-ordination with factory owners, active case finding at factories can increase awareness and confidence among workers to seek care.
Prachi Shukla

EP30-388-24-TB treatment outcomes among patients identified through active case finding in a high-density, urban township in Lusaka, ZambiaActive case finding is gaining traction as a means to find missing TB cases in communities as we aim to achieve the End TB Strategy. It identifies individuals who otherwise would spread the disease and further fuel the epidemic. Ever wondered what happens to TB patients identified in this manner? 
Sulani Nyimbili

EP30-389-24-The yield of school-based active TB case finding in Oromia Region of EthiopiaIn the Oromia Region of Ethiopia, which has a high TB burden, school-based TB screening is an advantage. Additional TB cases can be identified in school settings and there is the added advantage of engaging school students in community and household presumptive TB referrals.

Bizuneh Alemu Fetenesa

EP30-390-24-Strengthening active TB case finding: results from using an active case finding toolkit at health facilities in UgandaWith one-quarter of estimated tuberculosis (TB) patients missed, the Ugandan Ministry of Health developed active case finding toolkits to improve the quality of TB screening, case detection and treatment at health facilities. Strengthening health worker capacity to implement the toolkit improved performance and should be scaled-up to address gaps in TB notification.
Aldomoro Burua

EP30-391-24-Active TB case finding among HIV key populations and their contacts: an effective intervention modelThe key populations (KPs) for HIV (MSM and FSW) and their close community (KPC) are at an increased risk of tuberculosis (TB). Active TB case finding activities from PSI TOP centres can detect additional TB cases among non PLHIV KPs and their contacts and percentage of TB cases were higher than KPs.
Nandi U

EP30-392-24-Integrating TB case finding into house-to-house polio vaccination campaigns: findings from the July 2019 supplemental immunisation activities in Anambra State, NigeriaWe leveraged the World Health Organization-supported community polio vaccination structure to integrate tuberculosis (TB) case finding into a house-to-house vaccination campaign. Presumptive and confirmed TB cases were reported through the process. Our report shows that the intervention was most productive in peri-urban slums, riverine and hard-to-reach areas. 
Chukwuebuka Ugwu

EP30-393-24-Intensified case finding among outpatients and their companions by using chest X-ray with artificial intelligence software for TB triaging in the PhilippinesThe companions of patients are not usually part of intensified case finding (ICF) for tuberculosis (TB). We included them in ICF in the Philippines by using chest X-ray with artificial intelligence software for TB triage, which resulted in a high TB case yield, from both patients and companions.
Nichel Marquez

Loading...
E-posters
EP35-Ongoing battle against the tobacco industry
event_note
Loading...
query_builder 10:00 - 11:00 | Event time (GMT+2)
query_builder - | Your time (GMT)
place Online Session/Virtual
card_travel E-poster session
mic English
EP35-Ongoing battle against the tobacco industry
*Please scroll down for more information*
All E-posters are accessible via the "E-posters" section of the conference platform until 30 November.

EP35-436-24-Tier-based tax system benefitted tobacco industries in BangladeshThe tax structure of cigarettes in Bangladesh is complex. Due to the tobacco industry's influence, tier-based tax systems benefit tobacco industries. British American Tobacco Bangladesh (BATB) has made a huge profit from a rise in retail prices of cigarettes rather than tax. The 10-year financial report of BATB’s has revealed this fact.
 
Sushanta Kumar Singha

EP35-437-24-Indoor and outdoor tobacco advertisement monitoring in Jakarta province 2019This study aimed to assess compliance of the existing outdoor tobacco advertising ban and the current condition of indoor tobacco advertising, in Jakarta Province, to extend the TAPS (Tobacco Advertising, Promotion and Sponsorship) ban policy to include ‘indoor tobacco advertising and display ban’.
Silvia Dini

EP35-438-24-Strengthening tobacco control in Madhya Pradesh through integration of COVID-19 and tobacco controlThe abstract is about the integration of COVID-19 control measures and tobacco control. The COVID-19 pandemic has given an opportunity to the tobacco control community for stronger enforcement and bans on tobacco products. The abstract discusses tobacco control during COVID-19 prevention measures.
Mukesh Kumar Sinha

EP35-439-24-Compliance assessment of electronic cigarette online sales following a nationwide ban of electronic cigarettes in IndiaSince 18th September 2019, India has completely prohibited all forms of vaping devices, including online sales of the products. Using a content analysis method across different websites, we assessed the internet e-cigarette vendors compliance with the law.
Beladenta Amalia

EP35-440-24-Public complaints against violations of smoke-free area regulations in the capital, region province of Jakarta in 2020This study aims to measure the level of compliance with the implementation of smoke-free regulations and to find out the current situation and steps needed to be taken in order to enforce the regulations, as well as increase the attention of the Jakarta Provincial Government to smoke-free violations so that they can immediately impose sanctions and actions.
Silvia Dini

EP35-441-24-Tobacco industry exploiting disaster situations to promote their image through CSR activities: an analysis of a series of cases in Sri LankaA study about Corporate Social Responsibility activities of the British American Tobacco subsidiary, Ceylon Tobacco Company, during disaster times in the post-framework convention on tobacco control ratification era in Sri Lanka.
Chinthika Perera

EP35-442-24-Tactics of the tobacco industry in defeating the proposal to ban single stick cigarette sales in Sri LankaAn investigative research study into tobacco industry tactics in defeating the proposal to ban single stick cigarette sales in Sri Lanka and how the proposal failed to gain cabinet approval, thus preventing its implementation.
Chinthika Perera

EP35-443-24-Availability of tobacco products during the nationwide curfew period following the COVID-19 pandemic in Sri LankaSri Lanka imposed a nationwide curfew starting on 20th March to control the spread of COVID-19. This study aimed to explore the availability of tobacco products during the curfew period in Sri Lanka. Mass media and social media were used to promote tobacco products, violating the regulations on tobacco advertisement and promotion.
Chinthika Perera

EP35-444-24-Tobacco industry targeting ministers in Sri Lanka: Ministry of Finance 1977-2020The Ministry of Finance is responsible for executing the government's economic policy in Sri Lanka. The objective of this study was to explore tobacco industry engagements of finance ministers serving from 1977 (year the economy opened) to 2020.
Chinthika Perera

Loading...
E-posters
EP31-Allied against TB: new and old partners
event_note
Loading...
query_builder 10:00 - 11:00 | Event time (GMT+2)
query_builder - | Your time (GMT)
place Online Session/Virtual
card_travel E-poster session
mic English
EP31-Allied against TB: new and old partners
*Please scroll down for more information*
All E-posters are accessible via the "E-posters" section of the conference platform until 30 November.

EP31-394-24-TB case yield of at-risk groups using modified screening algorithm in Nigeria secondary and tertiary healthcare facilitiesSystematic screening for tuberculosis (TB) in health facility settings and among priority groups, remains an important active case finding strategy in high burden TB countries. National TB programmes will benefit through more attention to accurate diagnosis and earlier start of treatment.
Chidubem Ogbudebe

EP31-395-24-Engaging informal healthcare providers in TB case identification: experiences from a project in IndiaInformal providers provide the bulk of the initial medical care for people in low-income communities. Tuberculosis (TB) care provided by these informal providers is characterised as non-diagnosis, misdiagnosis and delayed diagnosis and/or inappropriate treatment. Engaging them in TB care is crucial in reducing the delay in diagnosis and for the initiation of treatment.
Ramesh Dasari

EP31-396-24-Key acceptability constructs influence pharmacist participation during a diagnostic referral pilot in Ho Chi Minh City, Viet NamWe conducted a standardised survey to assess the perceptions of private pharmacists, who were engaged and trained as part of a diagnostic referral pilot, on seven constructs of healthcare intervention, acceptability and pilot implementation.
Tran Phuong TM

EP31-397-24-Determinants of TB suspects’ referrals by pharmacies and over-the-counter medicine shop operators for laboratory TB diagnosis in Eastern Region, Ghana: a telephone surveyUptake of community tuberculosis (TB) care in the Eastern region of Ghana is high on account of a collaboration between the regional TB Control programme and pharmacies. The first ever telephone survey in Ghana revealed that pharmacies and over-the-counter shop operators largely support TB referral.
Mavis Pear Kwabla

EP31-398-24-TB care in prisons in New DelhiPrison facilities encounter turmoil in the challenges faced in tuberculosis (TB) control practices due to a continuous high turnover of prisoners. This causes an increased chance of disease transmission in larger communities on their exposure. A cross-sectional survey was conducted utilising active case finding tools to study epidemiological parameters and concoct interventions following their release.
K. K. Chopra

EP31-399-24-How community pharmacies can contribute to early detection and treatment of TB patients in Viet Nam: a cross-sectional, simulated client surveyEarly diagnosis and treatment of tuberculosis (TB) is important for control, particularly in high burden settings. Pharmacies may serve as a conduit for referring presumptive TB patients for clinical investigation. Using a cross-sectional survey, we evaluated if community pharmacies in Viet Nam were capable of referring a simulated client with presumptive TB.
Shukry Zawahir

EP31-400-24-Police become partners in the gight against TB: experience from Kiambu County, KenyaTuberculosis (TB) case identification and infection prevention remain a challenge in the Kenya police service. Police staff, accused persons and reportees are at increased risk of TB due to the overcrowding and poor ventilation of police cells, vans and court holdings. Public health facilities are also less accessible and require travel time.
Gloria Wandeyi

EP31-401-24-Understanding profile and treatment practices of informal health care providers in RIPEND project implementation area, Telangana State, IndiaEngaging informal providers in tuberculosis (TB) care is important as a first point of contact for any initial medical care. It becomes crucial to understand their profile and treatment practices to devise effective mechanisms for their engagement. 

Vikas Panibatla

EP31-402-24-Implementing 100 percent outpatient department screening in a resource- limited setting: what has workedOne hundred percent outpatient department (OPD) screening  for tuberculosis (TB) was implemented in a faith-based hospital to ascertain its impact  on TB case finding using a top to bottom approach. Training and the institution of an OPD team showed a remarkable improvement in the total number of cases identified in this facility.
Chidimma Ezeobi -Okoye

EP31-403-24-Periodic performance review with patent medicine vendors: a fulcrum for improving TB case detection in the community - a case study of Nasarawa state, NigeriaThe search for strategies to effectively engage the private health sector, especially in finding and treating missing tuberculosis (TB) cases, has dominated discussion in recent years. Our intervention engages the patent medicine vendors, through the umbrella associations, in a periodic performance review to enhance TB case detection and notification.
Igbaji Basil Uguge

Loading...
Processing. Please wait.
Loading...